Management of Gastric Cancer Peritoneal Metastasis: IGCA Working Group Consensus Statements - PubMed
4 hours ago
- #Gastric Cancer
- #Peritoneal Metastasis
- #Consensus Statements
- Gastric cancer peritoneal metastasis (GCPM) is a common and poor-prognosis manifestation of advanced gastric cancer.
- The International Gastric Cancer Association (IGCA) convened 42 global experts from 15 countries to develop 13 consensus statements on GCPM management.
- A structured Delphi process with anonymous Likert-scale voting and a ≥70% consensus threshold was used to refine the statements.
- Consensus was achieved for all 13 statements among the working group in the first Delphi round, with 75-100% agreement.
- A broader group of 63 experts (including 21 from the working group) agreed on 12 of the 13 statements during the IGCC (2025) GCPM Consensus Session.
- No consensus (52% agreement) was reached on the best systemic treatment for GCPM, likely due to rapidly evolving developments in metastatic gastric cancer.
- The consensus provides globally relevant GCPM management strategies and highlights critical research gaps to improve patient outcomes.
- The goal is to improve care consistency, guide clinical decisions, and identify urgent research needs.